Technical Notes for Monday March 29th Dollar Tree (DLTR), a NASDAQ 100 stock moved above $115.45 extending an intermediate uptrend. CVS Health (CVS) moved above $76.38, $76.48 and $76.72 to a four year high extending an intermediate uptrend. Healthcare SPDRs (XLV) moved above intermediate resistance at $75.38. Healthcare Providers iShares (IHF) moved above $252.27 to an all-time high extending an intermediate uptrend. Mondelez (MDLZ), an S&P 100 stock moved above $60.00 to an all-time high extending an intermediate uptrend. Utilities SPDRs (XLU) moved above intermediate resistance at $63.71. Utility stocks and ETFs are anticipating favourable news from Biden’s infrastructure spending announcement on Wednesday. Exelon (EXS), an S&P 100 stock moved above $43.62 extending an intermediate uptrend. Duke Energy (DUK), an S&P 100 stock moved above $96.89 extending an intermediate uptrend. Xcel Energy (XEL), a NASDAQ 100 stock moved above intermediate resistance at $67.00. Trader’s Corner Equity Indices and Related ETFs Daily Seasonal/Technical Equity Trends for March 29th 2021 Green: Increase from previous day Red: Decrease from previous day Commodities Daily Seasonal/Technical Commodities Trends for March 29th 2021 Green: Increase from previous day Red: Decrease from previous day Sectors Daily Seasonal/Technical Sector Trends for March 29th 2021 Green: Increase from previous day Red: Decrease from previous day All seasonality ratings are based on performance relative to the S&P 500 Index S&P 500 Momentum Barometers The intermediate Barometer slipped 0.60 to 82.16 yesterday. It remains Extremely Overbought. The long term Barometer added 0.80 to 94.39 yesterday. It remains Extremely Overbought. TSX Momentum Barometers The intermediate Barometer slipped 2.07 to 65.55 yesterday. It remains Overbought. The long term Barometer slipped 0.58 to 77.99 yesterday. It remains Overbought. Disclaimer: Seasonality and technical ratings offered in this report and at www.equityclock.com are for information only. They should not be considered as advice to purchase or to sell mentioned securities. Data offered in this report is believed to be accurate, but is not guaranteed